𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma

✍ Scribed by Jeng-Wei Lu, Yueh-Min Lin, Jan-Gowth Chang, Kun-Tu Yeh, Rong-Ming Chen, Jeffrey J. P. Tsai, Wei-Wen Su, Rouh-Mei Hu


Book ID
118821752
Publisher
Springer US
Year
2013
Tongue
English
Weight
530 KB
Volume
30
Category
Article
ISSN
1357-0560

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Altered expression of cyclin D1 and CDK4
✍ Valeria Masciullo; Giovanni Scambia; Maria Marone; Cecilia Giannitelli; Gabriell πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 French βš– 130 KB πŸ‘ 2 views

We analyzed the expression and amplification of cyclin D1 and CDK4 genes in ovarian carcinomas. Northern blot analysis revealed overexpression of cyclin D1 in 12 of 65 (18%) ovarian carcinomas while CDK4 was overexpressed in 7 of 48 cases (14%). None of the tumors showed amplification of any of the

Inhibition of cyclin D1 expression by cy
✍ Xiaojian Zhou; Zhiyuan Zhang; Xiao Yang; Wantao Chen; Ping Zhang πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 431 KB πŸ‘ 2 views

## Abstract Cyclin D1 is a well‐known cell cycle regulator. Recently, its pro‐survival function has been revealed in several tumors. Because increasing expression of cyclin D1 is a common event in oral squamous cell carcinoma (OSCC) and has been correlated with cisplatin resistance, we investigated